Abstract
Helicobacter pylori infection is very common and affects more than one-third of adults in Italy. Helicobacter pylori causes several gastro-duodenal diseases, such as gastritis, peptic ulcer and gastric
malignancy, and extra-gastric diseases. The eradication of the bacteria is becoming
complex to achieve due to increasing antimicrobial resistance. To address clinical
questions related to the diagnosis and treatment of Helicobacter pylori infection, three working groups examined the following topics: (1) non-invasive and
invasive diagnostic tests, (2) first-line treatment, and (3) rescue therapies for
Helicobacter pylori infection. Recommendations are based on the best available evidence to help physicians
manage Helicobacter pylori infection in Italy, and have been endorsed by the Italian Society of Gastroenterology
and the Italian Society of Digestive Endoscopy.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Digestive and Liver DiseaseAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Global Prevalence of Helicobacter pylori infection: systematic review and meta-analysis.Gastroenterology. 2017; 153: 420-429
- Treatment of Helicobacter pylori infection: a clinical practice update.Eur J ClinInvest. 2018; 48
- Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.Gut. 2017; 66: 6-30
- GRADE guidelines: 3. Rating the quality of evidence.J Clin Epidemiol. 2011; 64: 401-406
- Effectiveness of management strategies for uninvestigated dyspepsia: systematic review and network meta-analysis.BMJ. 2019; 367: l6483
- ACG and CAG clinical guideline: management of dyspepsia.Am J Gastroenterol. 2017; 112: 988-1013
- Helicobacter pylori “Test-and-Treat” strategy with urea breath test: a cost-effective strategy for the management of dyspepsia and the prevention of ulcer and gastric cancer in Spain-Results of the Hp-Breath initiative.Helicobacter. 2020; 25: e12693
- Management of NSAID-associated peptic ulcer disease.Exp Rev Gastroenterol Hepatol. 2016; 10: 723-733
- Diagnosis and treatment of peptic ulcer disease and H. pylori infection.Am Fam Physician. 2015; 91: 236-242
- Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.Lancet (London, England). 2002; 359: 14-22
- Peptic ulcer bleeding risk. The role of Helicobacter pylori Infection in NSAID/Low-Dose Aspirin Users.Am J Gastroenterol. 2015; 110: 684-689
- Helicobacter pylori infection and iron stores: a systematic review and meta-analysis.Helicobacter. 2008; 13: 323-340
- Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysis.World J Gastroenterol. 2010; 16: 886-896
- Iron deficiency anaemia can be improved after eradication of Helicobacter pylori.Postgrad Med J. 2010; 86: 272-278
- Iron deficiency anemia in Helicobacter pylori infection: meta-analysis of randomized controlled trials.Scand J Gastroenterol. 2010; 45: 665-676
- Effect of Helicobacter pylori eradication on iron deficiency.Chin Med J (Engl). 2010; 123: 1924-1930
- Helicobacter pylori and extragastric diseases: A review.World J Gastroenterol. 2018; 24: 3204-3221
- Extra-gastric manifestations of Helicobacter pylori Infection.J ClinMed. 2020; 9: E3887
- Unique host iron utilization mechanisms of Helicobacter pylori revealed with iron-deficient chemically defined media.Infect Immun. 2010; 78: 1841-1849
- The role of prohepcidin in anemia due to Helicobacter pylori infection.Pediatr Hematol Oncol. 2013; 30: 425-431
- Association between Active H. pylori infection and iron deficiency assessed by serum hepcidin levels in school-age children.Nutrients. 2019; 11: E2141
- An updated systematic review and meta-analysis on the association between Helicobacter pylori infection and iron deficiency anemia.Helicobacter. 2017; : 22
- Vitamin B12 deficiency.N Engl J Med. 2013; 368: 2041-2042
- Micronutrients (Other than iron) and Helicobacter pylori infection: a systematic review.Helicobacter. 2012; 17: 1-15
- Hematologic manifestations of Helicobacter pylori infection.World J Gastroenterol. 2014; 20: 12818-12838
- [Chronic autoimmune gastritis : a multidisciplinary management].Rev Med Liege. 2019; 74: 598-605
- Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura.Helicobacter. 2007; 12: 36-42
- Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients.J Clin Invest. 2008; 118: 2939-2949
- Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment.World J Gastroenterol. 2014; 20: 12781-12808
- Single nucleotide polymorphism of interleukin-1beta associated with Helicobacter pylori infection in immune thrombocytopenic purpura.Tissue Antigens. 2009; 73: 353-357
- Helicobacter pylori eradication can induce platelet recovery in chronic idiopathic thrombocytopenic purpura.Platelets. 2006; 17: 227-230
- Long term platelet responses to Helicobacter pylori eradication in Canadian patients with immune thrombocytopenic purpura.Int J Hematol. 2008; 88: 212-218
- The significance of cagA(+) Helicobacter pylori in reflux oesophagitis.Gut. 2001; 49: 341-346
- Systematic review with meta-analysis: association of Helicobacter pylori infection with gastro-oesophageal reflux and its complications.Aliment Pharmacol Ther. 2021; 54: 988-998
- Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis.Clin Gastroenterol Hepatol. 2007; 5 (1417.e1-2): 1413-1417
- Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies.Am J Gastroenterol. 2002; 97: 2992-2997
- Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis.Am J Gastroenterol. 2010; 105 (quiz 1006, 1014): 1007-1013
- Effects of Helicobacter pylori eradication on gastroesophageal reflux disease.Helicobacter. 2011; 16: 255-265
- Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease.Gastroenterology. 2001; 121: 1120-1126
- Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety.Am J Gastroenterol. 1995; 90: 1401-1406
- Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication.N Engl J Med. 1996; 334: 1018-1022
- Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.Gut. 2006; 55: 1538-1544
- Potential mechanism of corpus-predominant gastritis after PPI therapy in Helicobacter pylori-positive patients with GERD.World J Gastroenterol. 2014; 20: 11962-11965
- Prevalence of Helicobacter pylori infection in sexual partners of H. pylori-infected subjects: Role of gastroesophageal reflux.United Eur Gastroenterol J. 2018; 6: 1470-1476
- Accuracy of urea breath test in Helicobacter pylori infection: meta-analysis.World J Gastroenterol. 2015; 21: 1305-1314
- Non-invasive tests for the diagnosis of Helicobacter pylori: state of the art.Acta Biomed. 2018; 89: 58-64
- Review: Diagnosis of Helicobacter pylori infection.Helicobacter. 2019; 24: e12641
- Non-invasive diagnostic tests for Helicobacter pylori infection.Cochrane Database Syst Rev. 2018; 3CD012080
- Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis.Am J Gastroenterol. 2006; 101: 1921-1930
- Accuracy of monoclonal stool tests for determining cure of Helicobacter pylori infection after treatment.Helicobacter. 2010; 15: 201-205
- Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole.Aliment Pharmacol Ther. 2004; 20: 117-122
- Accuracy of a monoclonal antibody-based stool antigen test in the diagnosis of Helicobacter pylori infection.Scand J Gastroenterol. 2004; 39: 1073-1077
- Has H. pylori prevalence in bleeding peptic ulcer been underestimated? A meta-regression.Am J Gastroenterol. 2011; 106: 398-405
- Guidelines for the management of Helicobacter pylori infection in Italy: the III Working Group Consensus Report 2015.Dig Liver Dis. 2015; 47: 903-912
- Comparison of Helicobacter pylori stool antigen, salivary IgG, serum IgG, and serum IgM as diagnostic markers of H. pylori infection in children.Iran J Microbiol. 2019; 11: 206-211
- Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de EndoscopiaDigestiva (SPED) guideline update 2019.Endoscopy. 2019; 51: 365-388
- Diagnosis of Helicobacter pylori infection on gastric biopsies: Standard stain, special stain or immunohistochemistry?.Ann Pathol. 2018; 38: 363-369
- Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.Am J Surg Pathol. 1996; 20: 1161-1181
- Confirmation of successful therapy of Helicobacter pylori infection: number and site of biopsies or a rapid urease test.Am J Gastroenterol. 1995; 90: 1962-1964
- The best gastric site for obtaining a positive rapid ureas test.Helicobacter. 1996; 1: 256-259
- The use of a second biopsy from the gastric body for the detection of Helicobacter pylori using rapid urease test.Singapore Med J. 2014; 55: 644-647
- Urease-positive bacteria in the stomach induce a false-positive reaction in a urea breath test for diagnosis of Helicobacter pylori infection.J Med Microbiol. 2008; 57: 814-819
- Noninvasive molecular analysis of Helicobacter pylori: Is it time for tailored first-line therapy?.World J Gastroenterol. 2017; 23: 2453-2458
- Helicobacter pylori primary and secondary genotypic resistance to clarithromycin and levofloxacin detection in stools: A 4-Year scenario in Southern Italy.Antibiotics (Basel). 2020; 9: E723
- Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016.Scand J Gastroenterol. 2018; 53: 661-664
- The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.Gastroenterology. 2016; 151 (e14): 51-69
- Meta-analysis of three-in-one single capsule bismuth-containing quadruple therapy for the eradication of Helicobacter pylori.Helicobacter. 2019; 24: e12570
- The “three-in-one” formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practice.Helicobacter. 2018; 23: e12502
- Effectiveness and Safety of Pylera® in patients infected by Helicobacter pylori: a multicenter, retrospective, real life study.DigDis. 2018; 36: 264-268
- Eradication rates in Italian subjects heterogeneously managed for Helicobacter pylori infection. Time to abandon empiric treatments in Southern Europe.J Gastrointestin Liver Dis. 2017; 26: 129-137
- Quadruple, sequential, and concomitant first-line therapies for H. pylori eradication: a prospective, randomized study.Dig Liver Dis. 2018; 50: 139-141
- Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study.Helicobacter. 2020; 25: e12694
- Sequential versus standard triple first-line therapy for Helicobacter pylori eradication.Cochrane Database Syst Rev. 2016; CD009034
- Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy.BMJ. 2013; 347: f4587
- Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice.Eur J Gastroenterol Hepatol. 2018; 30: 621-625
- Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial.Gut. 2016; 65: 1784-1792
- Optimum duration of regimens for Helicobacter pylori eradication.Cochrane Database Syst Rev. 2013; CD008337
- Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered?.Aliment Pharmacol Ther. 2012; 35: 1221-1230
- High dose dual therapy versus bismuth quadruple therapy for Helicobacter pylori eradication treatment: A systematic review and meta-analysis.Medicine (Baltimore). 2019; 98: e14396
- Current status of Helicobacter pylori eradication and risk factors for eradication failure.World J Gastroenterol. 2020; 26: 4846-4856
- Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection.Aliment Pharmacol Ther. 2012; 36: 414-425
- Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies.Helicobacter. 2017; 22https://doi.org/10.1111/hel.12392
- Efficacy of vonoprazan for Helicobacter pylori eradication.Intern Med. 2020; 59: 153-161
- Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication.J Antimicrob Chemother. 2019; 74: 772-774
- Worldwide H. pylori antibiotic resistance: a systematic review.J Gastrointestin Liver Dis. 2010; 19: 409-414
- European registry on helicobacter pylori management: effectiveness of first and second-line treatment in Spain.Antibiotics. 2020; 10: 13
- Guidelines for the management of Helicobacter pylori infection in Italy: the III Working Group Consensus Report 2015.DigLiverDis. 2015; 47: 903-912
- Helicobacter pylori eradication rates of concomitant and sequential therapies in Korea.Helicobacter. 2017; : 22
- Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection.Aliment Pharmacol Ther. 2016; 44: 427-437
- Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures.Aliment PharmacolTher. 2006; 24: 1469-1474
- Letter: third-line rescue therapy with levofloxacin after failure of two treatments to eradicate Helicobacter pylori infection.Aliment Pharmacol Ther. 2012; 35 (authorreply 1486): 1484-1485
- Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus.Gut. 2020; 69: 2093-2112
- Efficacies of genotypic resistance-guided vs empirical therapy for refractory helicobacter pylori infection.Gastroenterology. 2018; 155: 1109-1119
- Susceptibility-guided therapy for Helicobacter pylori infection treatment failures.Therap Adv Gastroenterol. 2019; 121756284819874922
- High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection.Aliment Pharmacol Ther. 2004; 19: 789-795
- Efficacy and tolerability of culture-guided treatment for Helicobacter pylori infection.Eur J Gastroenterol Hepatol. 2017; 29: 1258-1263
- Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection.Clin Gastroenterol Hepatol. 2013; 11: 507-510
- Efficacy of a multistep strategy for Helicobacter pylori eradication.Aliment Pharmacol Ther. 2000; 14: 79-83
- Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations.Aliment Pharmacol Ther. 2012; 36: 1076-1083
- Helicobacter pylori eradication in patients with peptic ulcer after two treatment failures: a prospective culture-guided study.Gastroenterol Hepatol. 2002; 25: 438-442
- Susceptibility-guided vs. empiric retreatment of Helicobacter pylori infection after treatment failure.Dig Dis Sci. 2006; 51: 2316-2321
- Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infection.J Antimicrob Chemother. 2015; 70: 2447-2455
- Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.Aliment Pharmacol Ther. 2006; 24: 395-403
- Efficacy and safety of high-dose dual therapy for Helicobacter pylori rescue therapy: a systematic review and meta-analysis.J Dig Dis. 2016; 17: 811-819
- High dose dual therapy versus bismuth quadruple therapy for Helicobacter pylori eradication treatment: a systematic review and meta-analysis.Medicine (Baltimore). 2019; 98: e14396
- European Registry on Helicobacter pylori management: single-capsule bismuth quadruple therapy is effective in real-world clinical practice.United Eur Gastroenterol J. 2021; 9: 38-46
- Rifabutin triple therapy is effective in patients with multidrug-resistant strains of Helicobacter pylori.J Clin Gastroenterol. 2018; 52: 137-140
- Rescue therapy with bismuth quadruple regimen in patients with Helicobacter pylori -resistant strains.Helicobacter. 2017; : 22
- Antibiotic resistance and therapy outcome in H. pylori eradication failure patients.Antibiotics (Basel). 2020; 9: E121
- Clinical application of probiotics in the treatment of Helicobacter pylori infection – a brief review.J Microbiol Immunol Infect. 2014; 47: 429-437
- Systematic review and meta-analysis: multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events.United Eur Gastroenterol J. 2016; 4: 546-561
Article info
Publication history
Published online: July 10, 2022
Accepted:
June 25,
2022
Received:
February 18,
2022
Identification
Copyright
© 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
